Featured
Last news
Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / April 1, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced the closing of its previously announced private placement.
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year
FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 annual report on Form 10-K on Tuesday, April 1, 2025. The following are highlights of the report:
MedMira Reports Second Quarter Results FY2025
HALIFAX, NS / ACCESS Newswire / April 1, 2025 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2025.
US robbers who touted crime on Instagram jailed
Bumbling robbers who left behind a cell phone during a $2.6 million heist and later boasted on Instagram about being part of a criminal gang have been jailed in California, authorities said Monday.
Syrians rejoice during first Eid after Assad's fall
Eid al-Fitr in Syria was charged with newfound joy this year, as thousands freely celebrated the holiday for the first time after the fall of Bashar al-Assad.
Iran will have 'no choice' but to acquire nukes if attacked: Khamenei adviser
Iran would have no alternative but to acquire a nuclear weapon if attacked by the United States or its allies, an adviser to the country's supreme leader warned on Monday, following a threat by Donald Trump.
France's Le Pen defiant after five year election ban
French far-right leader Marine Le Pen on Monday slammed a "political decision" and insisted she had not abandoned hope of standing in presidential elections in 2027 after a court handed her a five-year ban on running for office.
Israel's Netanyahu slams Qatargate probe as 'political witch hunt'
Israel's Prime Minister Benjamin Netanyahu testified Monday in a probe involving alleged payments from Qatar to some of his aides, an investigation he denounced as politically motivated.
Myanmar to mark minute of silence as quake toll passes 2,000
Myanmar will mark a minute of silence Tuesday in tribute to victims of the country's devastating earthquake that has killed more than 2,000 people, as hopes dim of finding more survivors in the rubble of ruined buildings.
Spain coal mine blast kills five
Five people died and another four were seriously injured in a blast Monday at a coal mine in northern Spain's Asturias region, the nation's deadliest mining accident in decades.
Top aide to Israel's Netanyahu arrested in 'Qatargate' probe
Israeli police announced on Monday the arrest of two individuals, one of whom was confirmed by Prime Minister Benjamin Netanyahu's ruling Likud party as a senior aide to the long-serving leader.
Myanmar declares week of mourning as quake toll passes 2,000
Myanmar declared a week of national mourning on Monday over the country's devastating earthquake, as the death toll passed 2,000 and hopes faded of finding more survivors in the rubble of ruined buildings.
Fear of aftershocks in Myanmar forces patients into hospital car park
Hundreds of patients, including babies, the elderly and Buddhist monks, lie on gurneys in a hospital car park in the sweltering heat of Mandalay, a city still living in fear of aftershocks three days after a deadly quake struck Myanmar.
Le Pen's French presidency bid in jeopardy after election ban
A French court on Monday threw into severe doubt far-right leader Marine Le Pen's 2027 bid for president, handing her a five-year ban on running for office after convicting her over a fake jobs scheme.
Myanmar declares week of mourning as quake toll passes 2,000, hopes fade for survivors
Myanmar declared a week of national mourning on Monday for the country's devastating earthquake, as the death toll passed 2,000 and hopes faded of finding more survivors in the rubble of ruined buildings.
Probe accuses ex J-pop star Nakai of sexual assault
An independent panel investigating allegations against an J-pop megastar-turned-TV host accused him on Monday of sexual violence against a Fuji Televsision employee, saying the company's handling of the matter amounted to harassment of the employee.
France fines Apple 150 million euros over privacy feature
French antitrust authorities handed Apple a 150-million-euro ($162-million) fine on Monday over its app tracking privacy feature, which is also under scrutiny in several other European countries.
Thai authorities probe collapse at quake-hit construction site
Authorities in Thailand are investigating possible factors that led to the devastating collapse of a Bangkok construction site, where dozens remained missing on Monday, three days after a massive earthquake centred in Myanmar.
Myanmar declares week of mourning as hopes fade for quake survivors
Myanmar's ruling junta declared a week of national mourning on Monday for the country's devastating earthquake, which has killed more than 1,700 people, as hopes faded of finding more survivors in the rubble of ruined buildings.
Tears in Taiwan for relatives hit by Myanmar quake
As images of destroyed buildings in earthquake-hit Myanmar flashed across her television screen in Taiwan, Yang Bi-ying could only weep for her family there.
'Devastated': Relatives await news from Bangkok building collapse
Three days after a Bangkok skyscraper collapsed in the wake of a devastating earthquake in neighbouring Myanmar, Naruemol Thonglek is still praying that her boyfriend will emerge from the immense pile of rubble where the building once stood.
Prayers and tears for Eid in quake-hit Mandalay
Hundreds of grieving Muslims gathered for Eid prayers in the street in Mandalay on Monday, the death and destruction of Myanmar's huge earthquake casting a pall of anguish over the occasion.
UK imposes travel permit on Europeans from Wednesday
In a shake-up of long-standing travel rules, European nationals heading to the UK will from Wednesday need a mandatory entry permit, which the British government says will strengthen border security.
Duterte lawyer: 'compelling' grounds to throw case out
Rodrigo Duterte's lead lawyer said Sunday there was a "compelling" argument to throw out the International Criminal Court case against the former Philippines president before it even comes to trial.
Rescue hopes fading three days after deadly Myanmar quake
Hopes were fading Monday of finding more survivors in the rubble of Mandalay, where some residents spent a third night sleeping in the open after a massive earthquake killed at least 1,700 people in Myanmar and neighbouring Thailand.
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
LONDON, GB / ACCESS Newswire / March 31, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued share capital of the Company as at 31 March 2025 consists of 4,093,539 ordinary shares of 1p each, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 4,093,539.
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.
Interactive Strength Inc. (Nasdaq: TRNR) Reports Fourth Quarter & Year-End 2024 Results
Company Delivers Quarterly Revenue of $2.4 Million as Projected or $5.4 Million for full-year 2024Quarterly Net Loss and Earnings per Diluted Share of $5.8 Million and $7.26Quarterly Adjusted EBITDA Loss of $1.9 Million Reflects 42% Improvement YOY and 19% SequentiallyStockholders' Equity Was $7.1 Million at Year EndPending Acquisitions Remain on Track; TRNR Expects More than $50M in 2025 Pro Forma Revenue
Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to prevent lower respiratory tract disease caused by RSV infection in adults aged 60 years and older.1 mRESVIA's approval marks a significant milestone as it is the first mRNA vaccine in Australia approved for use against a disease beyond COVID-19."We are pleased to receive regulatory approval for mRESVIA in Australia following the TGA's decision," said Stéphane Bancel, Chief Executive Officer of Moderna. "This approval underscores our commitment to protecting older adults from RSV-related respiratory diseases. We look forward to supplying mRESVIA from our Melbourne facility to older Australians vulnerable to RSV in the future."
The Battery Show South Announces Keynote Speakers Covering the Battery Belt, Energy Storage and Market Disruptions
ATLANTA, GA / ACCESS Newswire / March 31, 2025 / The Battery Show South and Electric & Hybrid Vehicle Technology Expo South, the region's leading event for battery manufacturing and electric vehicle technology, today announces its keynote speakers for the inaugural event taking place April 16-17, 2025, at the Georgia World Congress Center. Attendees will hear from industry experts including Cristina Paredes, Executive Director of SC Nexus for Advanced Resilient Energy, and Christian Hofer, Vice President of Market Operations at Key Capture Energy (KCE) on the developments and trends shaping the economics and energy sector in the Battery Belt and beyond.
Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that it has entered into definitive agreements, providing the Company with an aggregate gross proceeds of approximately $1.1 million, for the issuance and sale of an aggregate of 315,188 of its shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $3.49 per share (or common stock equivalent in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company has also agreed to issue and sell unregistered Series A-5 warrants to purchase up to an aggregate of 315,188 shares of common stock and unregistered Series A-6 warrants to purchase up to an aggregate of 315,188 shares of common stock. The Series A-5 warrants and the Series A-6 warrants will have an exercise price of $3.24 per share and will be exercisable immediately upon issuance. The Series A-5 warrants will have a term of eighteen months from the date of issuance and the Series A-6 warrants will have a term of five years from the date of issuance. The offering is expected to close on or about March 31, 2025, subject to the satisfaction of customary closing conditions.
Licensing Expo Celebrates Female Leaders Shaping the Future of Licensing Events
Global tradeshow spotlights innovative executives driving critical growth, advocacy and transformation in the expanding licensing sector.